R. Baughman (Cincinnati, United States of America), H. Nunes (Bobigny, France), D. Bouvry (Bobigny, France), A. Morais (Maia, Portugal)
Late Breaking Abstract - Characteristics of macrophagal formula and cytokine spectrum of the bronchoalveolar lavage fluid in patients with newly diagnosed and those with recurring sarcoidosis of respiratory apparatus.
N. Makaryants (MOSCOW, Russian Federation), A. Ergeshov (MOSCOW, Russian Federation), N. Demyanenko (MOSCOW, Russian Federation), L. Lepekha (MOSCOW, Russian Federation), E. Shmelev (MOSCOW, Russian Federation)
|  |
Late Breaking Abstract - Reduced activity of energy-transducing NADH-quinone oxidoreductase (complex I) indicates mitochondrial respiratory chain dysfunction in patients with sarcoidosis
O. Kotsiou (Larissa, Greece), Z. Daniil (Larissa, Greece), E. Bouzetos (Larissa, Greece), H. Panagiotidou (Larissa, Greece), M. Fouka (Larissa, Greece), F. Malli (Larissa, Greece), F. Bardaka (Larissa, Greece), K. Antoniou (Heraklion, Greece), A. Psara (Larissa, Greece), Z. Mamuris (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), E. Zifa (Larissa, Greece)
| |
Retrospective analysis of sarcoidosis characteristics and psychological impact between civilian and military populations.
C. Ranc (Clamart, France), O. Bylicki (Clamart, France), H. Le Floch (Clamart, France), W. Gaspard (Clamart, France), L. Zhang (Clamart, France), F. Grassin (Clamart, France), F. Riviere (Clamart, France)
| |
Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients
A. Kiani (Tehran, Islamic Republic of Iran), A. Eslaminejad (Tehran, Islamic Republic of Iran), M. Shafie Pour (Kerman, Islamic Republic of Iran), F. Razavi (Tehran, Islamic Republic of Iran), S. Seyyedi (Tehran, Islamic Republic of Iran), B. Sharif- Kashani (Tehran, Islamic Republic of Iran), K. Taghavi (Tehran, Islamic Republic of Iran), A. Abedini (Tehran, Islamic Republic of Iran)
| |
Gender and smoking – does it matter for lung function in sarcoidosis? An analysis of large cohort (n=1260) Caucasian patients.
P. Boros (Warsaw, Poland), M. Martusewicz-Boros (Warsaw, Poland), S. Wesolowski (Warsaw, Poland)
| |
Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease
M. Labor (Osijek, Croatia), G. Pavlisa (Zagreb, Croatia), M. Alilovic (ZAgreb, Croatia)
|  |
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
D. Terrington (Norwich, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Peel (Norwich, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Wilson (Norwich, United Kingdom)
| |
The comparative characteristics of mediastinal lymphadenopathies in granulomatous pulmonary diseasesMakaryants N., Lepekha L., Sivokozov I., Semenova A.Central TB Research Institute, Moscow, Russia
N. Makaryants (Moscow, Russian Federation)
| |
Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
S. Alparslan Bekir (ISTANBUL, Turkey), E. Sonkaya (ISTANBUL, Turkey), F. Ozbaki (ISTANBUL, Turkey), S. Aydogan Eroglu (ISTANBUL, Turkey), L. Sertçelik (ISTANBUL, Turkey), D. Duman (ISTANBUL, Turkey), M. Kavas (ISTANBUL, Turkey), M. Çoban Agca (ISTANBUL, Turkey), I. Erdem (ISTANBUL, Turkey), I. Özmen (ISTANBUL, Turkey), S. Boga (ISTANBUL, Turkey), F. Armagan Hazar (ISTANBUL, Turkey), T. Sevim (ISTANBUL, Turkey), H. Türker (ISTANBUL, Turkey), Z. Karakurt (ISTANBUL, Turkey)
| |
Glucocorticosteroid therapy as predisposing factor for pulmonary sarcoidosis relapse
I. Merenkova (Kiev, Ukraine), Y. Dziublyk (Kiev, Ukraine), G. Gumeniuk (Kiev, Ukraine), M. Gumeniuk (Kiev, Ukraine)
| |
Predictive value of Neutrophil-to-lymphocyte ratio(NLR) and Platelet-to-lymphocyte ratio(PLR) in patients with Sarcoidosis
E. Yalniz (izmir, Turkey), F. Ucsular (izmir, Turkey), G. Karadeniz (izmir, Turkey), G. Polat (izmir, Turkey), G. Vayisoglu (izmir, Turkey)
| |
Monocytes and dendritic cells with hyperinflammatory profile in lungs of sarcoidosis patients
R. Lepzien (Stockholm, Sweden), S. Liu (Stockholm, Sweden), S. Kullberg (Stockholm, Sweden), A. Eklund (Stockholm, Sweden), J. Grunewald (Stockholm, Sweden), A. Smed-Sörensen (Stockholm, Sweden)
| |
Long-term outcomes of rituximab (RTX) therapy in recurrent Granulomatosis with Polyangiitis (GPA)
D. Gawryluk (Warsaw, Poland), J. Fijolek (Warsaw, Poland), E. Wiatr (Warsaw, Poland)
| |
Long-term follow-up of patients with pulmonary sarcoidosis
Y. Garmash (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation)
| |
Evaluation of specific immune complexes in patients with pulmonary sarcoidosis.
U. Zinchenko (St. Petersburg , Russian Federation), A. Starshinova (St. Petersburg , Russian Federation), M. Filatov (St. Petersburg , Russian Federation), V. Burdakov (St. Petersburg , Russian Federation), S. Landa (St. Petersburg , Russian Federation), N. Denisova (St. Petersburg , Russian Federation), P. Yablonskiy (St. Petersburg , Russian Federation)
| |
Clinical features and prognosis of Chinese sarcoidosis patients.
x. ma (BeiJing, China), H. Dai (BeiJing, China), C. Wang (BeiJing, China)
| |
Dynamics of the incidence and primary disability of sarcoidosis in Belarus
H. Baradzina (Minsk, Belarus)
| |
Sarcoidosis: imagiological findings and their impact on the disease outcome
R. Estêvão Gomes (Lisboa, Portugal), M. Barata (Lisboa, Portugal), C. Monge (Lisboa, Portugal), M. Lopes (Lisboa, Portugal), J. Soares (Lisboa, Portugal), J. Duarte (Lisboa, Portugal)
| |
Psychological impact of diffuse infiltrative lung disease
l. Loued (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), S. Cheikhrouhou (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), M. Mjid (Tunis, Tunisia), S. Meraii (Tunis, Tunisia)
| |